Interesting news on two companies that can be bought on FT
Source - ROBO Brief from ROBO GLOBAL
Diabetes Tech Shows Promise
With the annual American Diabetes Association meeting in a few weeks, we wanted to point out some new diabetes technology on the Horizon. Pun intended, HTEC member Insulet plans to present a glimpse of Horizon, its new closed-loop device currently under development. Closed-loop means that Insulet’s insulin pump will be integrated with the continuous glucose monitoring (CGM) device of another HTEC member, Dexcom, to help streamline insulin dosing for the times when it’s needed most.
On the private company side, Companion Medical is another company to watch. It offers the only FDA-approved smart insulin pen, and is in its earliest days of adoption with a multibillion dollar addressable market. With this and other new technology on the rise, we are still in the early innings of innovation of diabetes management, and expect more disruption for years to come.